期刊文献+

银杏叶提取物对急性脑梗死患者血小板磷酸二酯酶3及相关因素的影响 被引量:13

Effect of Ginkgo Biolba Extract on Platelet PDE 3 Activity and the Correlative Factors of Patients with Acute Cerebral Infarction
下载PDF
导出
摘要 目的临床验证银杏叶提取物(ginkgo biolba extract,EGB)对急性脑梗死患者血小板磷酸二酯酶3(phos-phodiesterase3,PDE3)活性及其相关因素的影响,观察其临床疗效。方法 30例急性脑梗死患者为对照组,接受常规治疗。15例急性脑梗死患者,常规治疗外给予EGB治疗。分别于用药前、用药后第1、3、7、14天测定两组患者血小板PDE3活性、环腺苷酸(cylic adenosine monophosphate,cAMP)水平、胞浆游离钙离子([Ca2+]i)水平,并于用药前及用药后第14天进行神经功能缺损评分、血液流变学检查,作为临床疗效评价指标。结果 EGB可使急性脑梗死患者血小板PDE3活性进一步下降,大大提升cAMP水平,降低胞浆[Ca2+]i浓度,改善血液流变学及神经功能缺损情况。结论 EGB可使急性脑梗死患者血小板PDE3活性进一步下降,加强PDE3在脑梗死急性期的保护作用,有效抑制血小板聚集,改善血液循环及神经功能缺损。 Objective To observe the effect of ginkgo biolba extract(EGB) on phosphodiesterase 3(PDE 3) activity and the correlative factors in patients with acute cerebral infarction,and verify the therapeutic effect of EGB.Methods Fifteen patients with acute cerebral infarction received EGB administration besides common therapy.Control group(30 patients with acute cerebral infarction) received common therapy.Platelet PDE 3 activity,cylic adenosine monophosphate(cAMP) levels and i concentration of both groups were detected in various timepoints(before treatment and the 1st,3rd,7th,14th day after treatment).Clinic indexes(neurologic impairment and hemorheology) were evaluated before treatment and at 14th day after treatment.Results EGB inhibited the platelet PDE 3 activity of patients with acute cerebral infarction,greatly increased the cAMP levels,lowered the i concentration,and improved the hemorheology and neurologic impairment of the patients.Conclusion In acute stage of cerebral infarction,EGB can significantly inhibit patients' platelet PDE 3 activity,increase cAMP,decrease i,and relieve clinical symptoms.
出处 《华南国防医学杂志》 CAS 2011年第3期206-209,共4页 Military Medical Journal of South China
关键词 银杏叶提取物 磷酸二酯酶 环核苷酸 钙离子 血小板聚集 急性脑梗死 Ginkgo biloba extract Phosphodiesterase Cylic nucleotides Calcium ion Platelet aggregation Acute cerebral infarction
  • 相关文献

参考文献10

  • 1Kyoko K,Toshiki M,Shinji N,et al.Toborinone and olprinone,phosphodiesterase III inhibitors,inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry[J].J Anesth,2004,18(2):107-112.
  • 2Yasmin S,Miranda F,James H,et al.Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity,intracellular cAMP and calcium in the heart[J].Cardiovas Drug Ther,2002,16(11):417-427.
  • 3Mayr FB,Jilma B.Current developments in anti-platelet therapy[J].Wien Med Wochenschr,2006,156(17-18):472-480.
  • 4Kambayashi J,Liu Y,Sun B,et al.Cilostazol as a unique antithrombotic agent[J].Curr Pharm Des,2003,9(28):2289-2302.
  • 5Goto S.Cilostazol:potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding[J].Atheroscler Suppl,2005,6(4):3-11.
  • 6Jeon YH,Heo YS,Kim CM,et al.Phosphodiesterase:overview of protein structures potential therapeutic applications and recent progress in drug development[J].Cell Mol Life Sci,2005,62(11):1198-1220.
  • 7Sheu MY,Shen YT,Sheng CK,et al.Ihibition of platelet function by A02131-1,a novel inhibitor of cGMP-specific phosphodiesterase,in vitro and in vivo[J].Blood,1996,87(9):3758-3767.
  • 8Ishiwata N,Noguchi K,Kawanishi M,et al.NT-702 (parogrelil hydrochloride,NM-702),a novel and potent phosphodiesterase inhibitor,improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model[J].Life Sci,2007,81(12):970-978.
  • 9De Feudis FV.Ginkgo biloba extract (EGb 761):pharmacological activities and clinical applications[M].Amsterdam:Elsevier,1991:1187.
  • 10Victor SS,Bernd W,Mark B.Ginkgo biloba[J].Am Fam Physician,2003,68(5):923.

同被引文献200

引证文献13

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部